282 related articles for article (PubMed ID: 7177469)
1. [Radioimmunologic determination of circulating parathyroid hormone in patients with primary and secondary hyperparathyroidism].
Lo Giudice C; Cascone C; Manente P; Gasparoni P; De Luca M; Rota G; Conte N
Minerva Med; 1982 Dec; 73(48):3425-8. PubMed ID: 7177469
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure.
Gautvik KM; Gautvik VT; Halvorsen JF
Scand J Clin Lab Invest; 1983 Nov; 43(7):553-64. PubMed ID: 6658372
[TBL] [Abstract][Full Text] [Related]
3. Comparison of C-terminal and N-terminal PTH in secondary hyperparathyroidism in renal failure.
Hortling L; Puutula-Räsänen L; Fyhrquist F
Scand J Urol Nephrol Suppl; 1985; 90():51-4. PubMed ID: 3868028
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
Novikov AI
Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
[No Abstract] [Full Text] [Related]
6. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone: radioimmunoassay and clinical interpretation.
Hawker CD
Ann Clin Lab Sci; 1975; 5(5):383-98. PubMed ID: 1180481
[TBL] [Abstract][Full Text] [Related]
8. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
9. The influence of parathyroid hormone and its fragments on results from midregion and C-terminal specific radioimmunoassays.
Kübler N; Krause U; Wagner PK; Beyer J; Rothmund M
Exp Clin Endocrinol; 1987 Mar; 89(1):61-9. PubMed ID: 3595732
[TBL] [Abstract][Full Text] [Related]
10. Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism.
Brandão CM; Kasamatsu TS; Oliveira MA; Vieira JG
Braz J Med Biol Res; 1989; 22(8):963-5. PubMed ID: 2633848
[TBL] [Abstract][Full Text] [Related]
11. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
12. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
13. [Immunological differences between primary and secondary hyperparathyroidism: studies by means of radioimmunological determination of plasma parathyroid hormone].
Mazzuoli G; Scarda A; Coen G; Guglielmi G; D'Erasmo E; Rizzo G
Boll Soc Ital Biol Sper; 1974 Aug; 50(15):1187-93. PubMed ID: 4458702
[No Abstract] [Full Text] [Related]
14. [Hyperparathyroidism secondary to renal insufficiency: anatomo-clinical relations and the potential role of an aluminum overload].
Mendes V; Jorgetti V; Nemeth J; Lavergne A; Lecharpentier Y; Cournot-Witmer G; Dubost C; Bourdon R; Bourdeau A; Zingraff J
Nephrologie; 1984; 5(2):65-70. PubMed ID: 6483074
[TBL] [Abstract][Full Text] [Related]
15. Normal responsiveness of serum parathyroid hormone to beta-adrenergic blockade in patients with secondary hyperparathyroidism.
Kukreja SC; Williams GA; Vora NM; Hargis GK
Horm Metab Res; 1981 Apr; 13(4):233-5. PubMed ID: 6113198
[TBL] [Abstract][Full Text] [Related]
16. Homeostasis and action of parathyroid hormone in normal man and patients with mild renal failure.
Massry SG; Llach F; Singer FR; Kurokawa K; Coburn JW
Proc Eur Dial Transplant Assoc; 1975; 11():451-6. PubMed ID: 812084
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the diagnostic contribution of C-terminal and medio-regional determination of parathyroid hormone in man].
Demulder A; Michiels N; Brauman H
Pathol Biol (Paris); 1987 Feb; 35(2):145-51. PubMed ID: 3550622
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism--a consecutive series of 80 patients.
Lokey J; Pattou F; Mondragon-Sanchez A; Minuto M; Mullineris B; Wambergue F; Foissac-Geroux P; Noel C; de Sagazan HL; VanHille P; Proye CA
Surgery; 2000 Dec; 128(6):1029-34. PubMed ID: 11114639
[TBL] [Abstract][Full Text] [Related]
19. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
[No Abstract] [Full Text] [Related]
20. Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful?
Roshan A; Kamath B; Roberts S; Atkin SL; England RJ
Clin Otolaryngol; 2006 Jun; 31(3):198-203. PubMed ID: 16759239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
